Navigation Links
Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
Date:6/13/2012

MOGADORE, Ohio, June 13, 2012 /PRNewswire/ -- Omega Laboratories, Inc. recognizes and applauds yesterday's announcement that the remaining laboratory of those accredited by the College of American Pathologists (CAP) for forensic hair drug testing has decided to utilize Enzyme Immunoassay technology. This announcement comes after a decade of disagreement and confusion regarding differing methodologies and proprietary techniques. This change could signal that the hair testing industry has finally come to a consensus on the superiority of Enzyme Immunoassay technology as a screening method for drugs of abuse.

This announcement represents a unity of methodology within the hair testing industry, as all three major workplace hair testing laboratories now use EIA as their screening method of choice. Omega anticipates that this harmonization on screening methodologies will aid in the acceptance of hair testing by the Substance Abuse and Mental Health Services Administration (SAMHSA) and their Drug Testing Advisory Board (DTAB).

Omega Laboratories has chosen to use Enzyme Immunoassay (EIA) technology since its inception in 2000, citing superior accuracy, reliability, and low impact upon the environment. Omega's use of EIA for 12 years has contributed to its position as a leader in the hair testing industry, allowing Omega to be an active and successful participant in worldwide proficiency testing programs. In addition, it has aided Omega in securing prestigious international accreditations and Food and Drug Administration (FDA) clearances for the company's screening assays.

Enzyme Immunoassay (EIA) is a quick and cost effective biochemistry assay used to identify the presence of substances within specimens. When used for drugs of abuse screening, this technology allows laboratories to efficiently and accurately detect drugs of abuse in hair specimens, which can then be confirmed through GC/MS and LC/MS technology. Since the 1992 publication of a World Health Organization study, which highlights the benefits of EIA technology, EIA has become the prevailing method of choice worldwide.

A common predecessor of EIA is Radioimmunoassay (RIA), which uses radioactive signal to detect substances within a sample. Some members of the hair testing for drugs of abuse industry have continued to market the use of RIA technology, despite widespread knowledge that this practice creates radioactive waste, which raises environmental concerns.

"It is exciting to hear that another laboratory has joined Omega in using Enzyme Immunoassay technology," said Dr. John Vitullo, CEO of Omega Laboratories.  "We have used this technology at Omega for over 12 years with great success and we know that the adoption of EIA by our competitors will not only be better for the environment, but will also help to establish equivalence and convergence in hair testing results across different laboratories."

In addition to numerous international accreditations, Omega Laboratories has utilized EIA to receive FDA screening assay clearances for its Cocaine, Methamphetamine, PCP, and Opiates panels, and is the only hair testing laboratory to have documented clearance for Codeine, Oxycodone and Hydrocodone testing.

About Omega Laboratories, Inc. - Omega Laboratories, Inc. is a state-of-the-art facility providing laboratory-based hair and oral fluid testing for drugs of abuse to over 5,000 clients worldwide.  Omega currently holds ISO/IEC 17025 and CAP alternative specimen testing accreditations, as well as screening clearances from the FDA. Omega's reputation for performing accurate, timely and cost effective testing, coupled with an unmatched reputation for client service, has positioned Omega as the leader in the alternative specimen drug testing industry.  

http://www.omegalabs.net/

CONTACT: Mark Freemal, +1-800-665-5569


'/>"/>
SOURCE Omega Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
2. Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
3. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
4. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
5. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
6. Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences
7. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
8. CHPA Applauds Arizonas Adoption Of HB 2263
9. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
10. CHPA Applauds Alabamas Adoption Of HB 363
11. CHPA Applauds Alabama Senates Passage of Anti-Meth Bill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 2017 IRIDEX Corporation (Nasdaq: IRIX ... for the fourth quarter and 2016 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:2/22/2017)... , Feb. 22, 2017 Summary ... infarction partnering deals and agreements entered into by ... full report: http://www.reportlinker.com/p03605670-summary/view-report.html Description The ... understanding and access to partnering deals and agreements ... - Trends in partnering deals ...
(Date:2/22/2017)... , Feb. 22, 2017 Merrimack Pharmaceuticals, Inc. ... will host its Fourth Quarter 2016 investor conference call and ... The call will cover an update on ... quarter and full year 2016 financial results. A press release ... be issued the morning of Wednesday, March 1. Investors and ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... ... in recent years. The technology is so cutting edge, in fact, the U.S. ... for stem cell procedures. However, successful patient outcomes in certain clinical stem cell ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... its certification exam and eligibility requirements effective with the April 2017 testing period. ... 1995. , “The Care Manager Certified (CMC) exam is periodically re-calibrated to ...
(Date:2/22/2017)... Dallas, TX (PRWEB) , ... ... ... HCC Risk Adjustment solution leverages advanced data analytics to accurately understand each ... ensure proper reimbursement for a given population. This new solution helps transform ...
(Date:2/22/2017)... ... ... Doctors on Liens is continuing its steady expansion of medical specialties throughout ... North Valley Eye Medical Group in Mission Hills . Eye injuries and vision ... cases. These injuries have a major impact on the quality of life of ...
(Date:2/22/2017)... ... February 22, 2017 , ... Using the power of the ... simple online checklist. Over a period of just 24 months, thousands of individuals interested ... online checklist called T.A.D. , “The internet is not getting quieter. In fact it’s ...
Breaking Medicine News(10 mins):